Mediation of multiple pathways regulating cell proliferation, migration, and apoptosis in the human malignant glioma cell line U87MG via unphosphorylated STAT1: Laboratory investigation

Journal of Neurosurgery

Volumn 118, Issue 6, 2013, Pages 1239-1247

  Ju, Haitao ^a   Li, Xin ^b   Li, Hong ^c   Wang, Xiaojuan ^d   Wang, Hongwei ^e   Li, Yang ^b   Dou, Changwu ^e   Zhao, Gang ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b Basic Medical College   (China)

^c Department of Oncology ^*  (China)

^d FOSHAN UNIVERSITY   (China)

^e Affiliated People's Hospital of Inner Mongolia Medical University   (China)

Author keywords

Apoptosis; Gene therapy; Glioblastoma; Oncology; STAT1

Indexed keywords

CASPASE 3; CASPASE 9; MESSENGER RNA; PLASMID VECTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P21; RHODAMINE B; STAT1 PROTEIN;

ACETYLATION; APOPTOSIS; ARTICLE; BRAIN TISSUE; CELL COUNT; CELL GROWTH; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; FLOW CYTOMETRY; GENE THERAPY; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; BRAIN NEOPLASMS; CASPASE 3; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84878678718     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.3.JNS122051     Document Type: Article

References (40)

1. Arafat WO, Buchsbaum DJ, Gómez-Navarro J, Tawil SA, Olsen C, Xiang J, et al: An adenovirus encoding proapoptotic Bax synergistically radiosensitizes malignant glioma. Int J Radiat Oncol Biol Phys 55:1037-1050, 2003 (Pubitemid 36287008)
2. Badie B, Goh CS, Klaver J, Herweijer H, Boothman DA: Combined radiation and p53 gene therapy of malignant glioma cells. Cancer Gene Ther 6:155-162, 1999 (Pubitemid 129667769)
3. Barthson J, Germano CM, Moore F, Maida A, Drucker DJ, Marchetti P, et al: Cytokines tumor necrosis factor-α and interferon-γ induce pancreatic β-cell apoptosis through STAT1-mediated Bim protein activation. J Biol Chem 286:39632-39643, 2011
4. Bhanoori M, Yellaturu CR, Ghosh SK, Hassid A, Jennings LK, Rao GN: Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21(waf1/cip1). Oncogene 22:117-130, 2003 (Pubitemid 36152890)
5. Bleeker FE, Molenaar RJ, Leenstra S: Recent advances in the molecular understanding of glioblastoma. J Neurooncol 108:11-27, 2012
6. Buettner R, Mora LB, Jove R: Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8:945-954, 2002 (Pubitemid 35177340)
7. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, et al: Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 62:6205-6210, 2002 (Pubitemid 35244472)
8. Chen B, He L, Savell VH, Jenkins JJ, Parham DM: Inhibition of the interferon-γ/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STATbinding site in the p21WAF1 promoter region. Cancer Res 60: 3290-3298, 2000 (Pubitemid 30407929)
9. Chin YE, Kitagawa M, Su WC, You ZH, Iwamoto Y, Fu XY: Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272:719-722, 1996
10. Darnell JE Jr: STATs and gene regulation. Science 277:1630-1635, 1997 (Pubitemid 27446219)
11. Dodou K, Anderson RJ, Small DA, Groundwater PW: Investigations on gossypol: past and present developments. Expert Opin Investig Drugs 14:1419-1434, 2005 (Pubitemid 41601456)
12. Erratum in Expert Opin Investig Drugs 15:193, 2006
13. Duarte CW, Willey CD, Zhi D, Cui X, Harris JJ, Vaughan LK, et al: Expression signature of IFN/STAT1 signaling genes predicts poor survival outcome in glioblastoma multiforme in a subtype-specific manner. PLoS ONE 7:e29653, 2012
14. Durbin JE, Hackenmiller R, Simon MC, Levy DE: Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450, 1996 (Pubitemid 26058569)
15. Efimova EV, Liang HUA, Pitroda SP, Labay E, Darga TE, Levina V, et al: Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling. Int J Radiat Biol 85:421-431, 2009
16. Gorlia T, van den Bent MJ, Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, et al: Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 9:29-38, 2008
17. Haybaeck J, Obrist P, Schindler CU, Spizzo G, Doppler W: STAT-1 expression in human glioblastoma and peritumoral tissue. Anticancer Res 27 (6B):3829-3835, 2007
18. Huang S, Bucana CD, Van Arsdall M, Fidler IJ: Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells. Oncogene 21:2504-2512, 2002 (Pubitemid 34438103)
19. Jiang LJ, Zhang NN, Ding F, Li XY, Chen L, Zhang HX, et al: RA-inducible gene-I induction augments STAT1 activation to inhibit leukemia cell proliferation. Proc Natl Acad Sci U S A 108:1897-1902, 2011
20. Kalinina J, Peng J, Ritchie JC, Van Meir EG: Proteomics of gliomas: initial biomarker discovery and evolution of technology. Neuro Oncol 13:926-942, 2011
21. Kouri FM, Jensen SA, Stegh AH: The role of Bcl-2 family proteins in therapy responses of malignant astrocytic gliomas: Bcl2L12 and beyond. Scientific World Journal 2012:838916, 2012
22. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, et al: Long-term survival with glioblastoma multiforme. Brain 130:2596-2606, 2007 (Pubitemid 47511715)
23. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR: Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases. Science 278: 1630-1632, 1997 (Pubitemid 27516283)
24. Leanza EC, Hoshida MS, Costa AF, Fernandes CM, de Fatima Pereira Teixeira C, Bevilacqua E: Signaling molecules involved in IFN-γ-inducible nitric oxide synthase expression in the mouse trophoblast. Am J Reprod Immunol 58:537-546, 2007 (Pubitemid 350091191)
25. Leibowitz MS, Andrade Filho PA, Ferrone S, Ferris RL: Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunol Immunother 60:525-535, 2011
26. Manero F, Gautier F, Gallenne T, Cauquil N, Grée D, Cartron PF, et al: The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death. Cancer Res 66:2757-2764, 2006
27. Ramana CV, Grammatikakis N, Chernov M, Nguyen H, Goh KC, Williams BRG, et al: Regulation of c-myc expression by IFN-through Stat1-dependent and -independent pathways. EMBO J 19:263-272, 2000 (Pubitemid 30042708)
28. Raven JF, Williams V, Wang S, Tremblay ML, Muller WJ, Durbin JE, et al: Stat1 is a suppressor of ErbB2/Neu-mediated cellular transformation and mouse mammary gland tumor formation. Cell Cycle 10:794-804, 2011
29. Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, et al: Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells. Oncogene 19:3508-3520, 2000 (Pubitemid 30487448)
30. Shchors K, Yehiely F, Deiss LP: Cell Death Inhibiting RNA (CDIR) modulates IFN-gamma-stimulated sensitization to Fas/CD95/Apo-1 and TRAIL/Apo-2L-induced apoptosis. Cell Cycle 3:1606-1611, 2004 (Pubitemid 40521415)
31. Sironi JJ, Ouchi T: STAT1-induced apoptosis is mediated by caspases 2, 3, and 7. J Biol Chem 279:4066-4074, 2004 (Pubitemid 38198990)
32. Stephanou A, Brar BK, Knight RA, Latchman DS: Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 7:329-330, 2000 (Pubitemid 30192982)
33. Streffer JR, Rimner A, Rieger J, Naumann U, Rodemann HP, Weller M: BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells. J Neurooncol 56:43-49, 2002 (Pubitemid 34256617)
34. Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJB, Janzer RC, et al: Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10: 459-466, 2009
35. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
36. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193, 2010
37. Vogelbaum MA, Tong JX, Perugu R, Gutmann DH, Rich KM: Overexpression of bax in human glioma cell lines. J Neurosurg 91:483-489, 1999 (Pubitemid 29404442)
38. Wang S, Raven JF, Durbin JE, Koromilas AE: Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1. PLoS ONE 3:e3476, 2008
39. Wong AH, Durbin JE, Li S, Dever TE, Decker T, Koromilas AE: Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J Biol Chem 276:13727-13737, 2001
40. Zhan JF, Chen LH, Yuan YW, Xie GZ, Sun AM, Liu Y, et al: STAT1 promotes radioresistance of CD44(+)/CD24(-/low) cells in breast cancer. Exp Biol Med (Maywood) 236:418-422, 2011